These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18987428)

  • 1. Potentiation of the antidepressant-like effect of fluoxetine by aripiprazole in the mouse tail suspension test.
    Kamei J; Miyata S; Sunohara T; Kamei A; Shimada M; Ohsawa M
    J Pharmacol Sci; 2008 Nov; 108(3):381-4. PubMed ID: 18987428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the antidepressant, anxiolytic and memory-improving efficacy of aripiprazole and fluoxetine in ethanol-treated rats.
    Burda-Malarz K; Kus K; Ratajczak P; Czubak A; Hardyk S; Nowakowska E
    Drug Chem Toxicol; 2014 Jul; 37(3):281-9. PubMed ID: 24215604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.
    Sarkisyan G; Roberts AJ; Hedlund PB
    Behav Brain Res; 2010 May; 209(1):99-108. PubMed ID: 20097233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine and aripiprazole treatment following prenatal immune activation exert longstanding effects on rat locomotor response.
    Richtand NM; Ahlbrand R; Horn P; Tambyraja R; Grainger M; Bronson SL; McNamara RK
    Physiol Behav; 2012 May; 106(2):171-7. PubMed ID: 22342193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of selective serotonin reuptake inhibitors on immobility time in the tail suspension test in streptozotocin-induced diabetic mice.
    Kamei J; Miyata S; Morita K; Saitoh A; Takeda H
    Pharmacol Biochem Behav; 2003 May; 75(2):247-54. PubMed ID: 12873612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice.
    Bourin M; Chenu F; Prica C; Hascoët M
    Psychopharmacology (Berl); 2009 Sep; 206(1):97-107. PubMed ID: 19517098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test.
    Rogóż Z; Kabziński M; Sadaj W; Rachwalska P; Gądek-Michalska A
    Pharmacol Rep; 2012; 64(6):1391-9. PubMed ID: 23406749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant-like effect of coadministration of sulpiride and fluvoxamine in mice.
    Ago Y; Harasawa T; Itoh S; Nakamura S; Baba A; Matsuda T
    Eur J Pharmacol; 2005 Sep; 520(1-3):86-90. PubMed ID: 16140294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms.
    Egashira N; Okuno R; Matsushita M; Abe M; Mishima K; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
    Eur J Pharmacol; 2008 Sep; 592(1-3):103-8. PubMed ID: 18644366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of noradrenergic and serotonergic antidepressants in reducing immobility time in the tail suspension test.
    Fujishiro J; Imanishi T; Baba J; Kosaka K
    Jpn J Pharmacol; 2001 Mar; 85(3):327-30. PubMed ID: 11325027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of antidepressant and memory-improving efficacy of aripiprazole and fluoxetine in alcohol-preferring rats.
    Burda-Malarz K; Kus K; Ratajczak P; Czubak A; Nowakowska E; Jędrzejewski L; Sadowski C
    Acta Neuropsychiatr; 2014 Apr; 26(2):112-9. PubMed ID: 24855889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of aripiprazole augmentation in Japanese patients with major depressive disorder: a subgroup analysis and Montgomery-Åsberg Depression Rating Scale and Hamilton Rating Scale for Depression item analyses of the Aripiprazole Depression Multicenter Efficacy study.
    Ozaki N; Otsubo T; Kato M; Higuchi T; Ono H; Kamijima K;
    Psychiatry Clin Neurosci; 2015 Jan; 69(1):34-42. PubMed ID: 24965202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats.
    Moser PC; Sanger DJ
    Eur J Pharmacol; 1999 May; 372(2):127-34. PubMed ID: 10395092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
    O'Leary OF; Bechtholt AJ; Crowley JJ; Hill TE; Page ME; Lucki I
    Psychopharmacology (Berl); 2007 Jun; 192(3):357-71. PubMed ID: 17318507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test.
    Dhir A; Kulkarni SK
    Pharmacology; 2007; 80(4):239-43. PubMed ID: 17622775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus.
    Asaoka N; Nagayasu K; Nishitani N; Yamashiro M; Shirakawa H; Nakagawa T; Kaneko S
    Neuropharmacology; 2015 Aug; 95():261-8. PubMed ID: 25863120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with caffeine and its withdrawal modify the antidepressant-like activity of selective serotonin reuptake inhibitors in the forced swim and tail suspension tests in mice. Effects on Comt, Slc6a15 and Adora1 gene expression.
    Szopa A; Doboszewska U; Herbet M; Wośko S; Wyska E; Świąder K; Serefko A; Korga A; Wlaź A; Wróbel A; Ostrowska M; Terlecka J; Kanadys A; Poleszak E; Dudka J; Wlaź P
    Toxicol Appl Pharmacol; 2017 Dec; 337():95-103. PubMed ID: 29107002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant effects of combination of brexpiprazole and fluoxetine on depression-like behavior and dendritic changes in mice after inflammation.
    Ma M; Ren Q; Yang C; Zhang JC; Yao W; Dong C; Ohgi Y; Futamura T; Hashimoto K
    Psychopharmacology (Berl); 2017 Feb; 234(4):525-533. PubMed ID: 27844095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of fluoxetine plus olanzapine treatment in rats: a behavior, endocrine, and immediate-early gene expression analysis.
    Horowitz JM; Goyal A; Ramdeen N; Hallas BH; Horowitz AT; Torres G
    Synapse; 2003 Dec; 50(4):353-64. PubMed ID: 14556240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.